那他珠单抗
|
|
|
- CAS号:
- 189261-10-7
- 英文名:
- Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
- 英文别名:
- Natalizumab-Tysabri;Research Grade Natalizumab(DHC98801);inhibit,Inhibitor,Natalizumab,Integrin;Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
- 中文名:
- 那他珠单抗
- 中文别名:
- NATALIZUMAB ( 那他珠单抗 )
- CBNumber:
- CB03204652
- 分子式:
- C40H55N7O11S
- 分子量:
- 841.97
- MOL File:
- 189261-10-7.mol
|
|
|
那他珠单抗化学性质
-
储存条件:
-
Store at 4°C, do not freeze
-
|
那他珠单抗性质、用途与生产工艺
Natalizumab 是一种重组的人源化单克隆抗体，与 α4β1-整联蛋白 (α4β1-integrin) 结合并阻断其与血管细胞粘附分子 1 (VCAM-1) 的相互作用。Natalizumab 可用于复发缓解型多发性硬化症和克罗恩氏病的研究。Natalizumab 也可阻止淋巴细胞进入中枢神经系统，从而防止急性脱髓鞘复发。
Natalizumab, a recombinant, humanized antibody, binds to α4β1-integrin and blocks its interaction with VCAM-1. As a result, leukocyte migration into brain tissue is inhibited, reducing inflammation and preventing the formation of lesions. Natalizumab may also inhibit ongoing central nervous system (CNS) inflammation, mediated by leukocytes already present in the CNS, by interrupting the interactions between α4-integrin-expressing leukocytes and extracellular matrix proteins such as fibronectin and osteopontin.
Natalizumab binds rapidly and with high affinity to α4-integrin. Maximal binding (≥80% saturation), measured in vitro on isolated lymphocyte membranes, occurred 24 hours after intravenous (IV) doses of natalizumab 1 mg/kg to 6 mg/kg.
那他珠单抗
上下游产品信息
上游原料
下游产品
189261-10-7, 那他珠单抗 相关搜索:
- 高纯试剂
- 药物对照抗体
- 化学试剂
- NATALIZUMAB ( 那他珠单抗 )
- 189261-10-7
- inhibit,Inhibitor,Natalizumab,Integrin
- Research Grade Natalizumab(DHC98801)
- Natalizumab-Tysabri
- Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer